Replies to post #15001 on Biostax Corp (BTAX)

[MSDR]

I have these exact same questions for why they aren’t distributing LDN in Africa. Why aren’t they shipping these pill packets to Africa like they were supposed to. What happened to the guaranteed orders from Kenya?? Nigeria it has been approved..... what’s going on in these fronts??

1.9 million HIV/AIDS in Nigeria
1.6 million HIV/AIDS in Kenya.

I mean, if they could get 10% of this population (350,000) using LDN monthly at approx $20/month. I mean that’s only $84 million in Revs per year just on this.

[H1C]

Thanks -- yeah, I agree that meeting the endpoint of this trial would be huge. And even more so if LDN performs as strongly as I think it will [no one in the LDN arm (or very, very few) progresses to severe disease; are discharged significantly sooner].

This is a pretty large trial, double-blind, placebo controlled. It meets the 'gold standard' as far as trial design goes. With the world's attention fixated as it is right now on finding a treatment for Covid, a positive trial result would finally start to get LDN the attention it deserves from the medical profession. Hopefully by that point IMUN/Cytocom will be in a position to act and get this medication out there.